TFS CAPITAL LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 26 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$277,000
+225.9%
54,783
+67.6%
0.11%
+289.3%
Q1 2017$85,000
+400.0%
32,689
+213.8%
0.03%
+833.3%
Q2 2016$17,000
-68.5%
10,416
-55.8%
0.00%
-50.0%
Q4 2015$54,000
-34.1%
23,569
-47.1%
0.01%
-25.0%
Q3 2015$82,00044,5360.01%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders